M. Adachi

Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.

K. Harada, H. Yoshida, M. Sato, 1997, Cancer letters.

The treatment with differentiation- and apoptosis-inducing agent, vesnarinone, of a patient with oral squamous cell carcinoma

K. Harada, H. Yoshida, M. Sato, 2004, Apoptosis.

Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice.

K. Harada, T. Bando, H. Yoshida, 1995, Cancer letters.

Abnormality of serum immunoglobulins in chronic liver disease—immune complex like substances, abnormaly basic γ-globulin, secretory IgA and anti-DNA antibody

M. Makuuchi, M. Tatsuta, K. Torizuka, 1981, Gastroenterologia Japonica.